Scientific, Regulatory & Strategic Consulting Services For The Life Science Industry

Our Services

Business Asset Evaluation

Scientific evaluation of business assets for in-licensing activities, evaluation and analysis of data sets, due diligence and business intelligence builds.  Services include market analysis and pitch deck generation

Drug Discovery/Preclinical Development

Evaluation and recommendation of in vitro and in vivo animal models, pharmacology, toxicology, PK/PD studies, study design and protocol builds, target identification and report summaries.  Services include poster and presentation synthesis

Medical Writing/Regulatory Strategy

Report builds, IND and IB synthesis, NDA/BLA builds, preIND summaries, regulatory responses, FDA, EMA, PDMA.  Strategy for biologics, small molecule, cellular therapeutics.  505b1, 505b2, 505j

Clients we serve